The Identification of Prognostic Factors and Survival Statistics of Conventional Central Chondrosarcoma

Table 4

Oncologic outcome, survival.

Study	Disease-free survival	No evidence of disease	No evidence of disease after tumor relapse	Alive with disease	Dead of disease	Dead of other causes
Andreou et al., 2011 [15]	63%	73 (63%)	0	0	38 (33%)	4 (3.5%)
Angelini et al., 2012 [16]	79%	201 (68%)	33 (11%)	15 (5.1%)	35 (12%)	12 (4.1%)
Briccoli et al., 2002 [17]	71%	10 (71%)	⋅	2 (14%)	1 (7.1%)	1 (7.1%)
Cho et al., 2011 [18]	75%	24 (75%)	2 (6.3%)	3 (9.4%)	5 (16%)	0
de Camargo et al., 2010 [19]	89%	⋅	⋅	6 (13%)	3 (7%)	0
Donati et al., 2010 [20]	⋅	29 (94%)	2 (6.5%)	0	0	0
Donati et al., 2005 [21]	⋅	⋅	⋅	⋅	⋅	⋅
Gitelis et al., 1981 [22]	30%	⋅	⋅	⋅	⋅	⋅
Mavrogenis et al., 2013 [23]	⋅	⋅	⋅	⋅	⋅	⋅
Mitchell et al., 2000 [10]	⋅	⋅	⋅	⋅	⋅	⋅
Ozaki et al., 1996 [24]	62%	4 (19%)	9 (43%)	0	7 (33%)	1 (4.8%)
Staals et al., 2006 [25]	⋅	⋅	⋅	⋅	84 (76%)	⋅
van Maldegem et al., 2014 [26]	⋅	⋅	⋅	⋅	⋅	⋅

Including 6 treatment related deaths.